A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Simvastatin (ZOCOR)

Simvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.

First FDA approval2006-12-20
Generic availableYes · 11 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$190.2M in CY2024 Part D spend22.1M claims · 6.9M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.028/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.028
Across all dosage forms in distribution.
Highest NADAC
$0.028
Range is tight.
Plans with PA
5 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Simvastatin used for?

Simvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.

Is there a generic for Simvastatin?

Yes. 54 ANDAs filed at FDA, 11 generic manufacturers currently shipping.

How much does my plan pay for Simvastatin?

Across 329 Part D plans, Simvastatin averages $0.028/unit (NADAC). Lowest available: $0.028/unit. Highest in distribution: $0.028/unit.

Is Simvastatin on the FDA shortage list?

No. Simvastatin is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

HMG-CoA Reductase Inhibitor5 alternatives in D1
01
Atorvastatin
Brand: Lipitor
$0.025Lowest NADAC
22Generic mfrs
$1.20BCY24 Part D spend
Compare →
02
Ezetimibe and Simvastatin
Brand: VYTORIN
$0.318Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →
03
Lovastatin
HMG-CoA Reductase Inhibitor
$0.038Lowest NADAC
7Generic mfrs
$38.5MCY24 Part D spend
Compare →
04
Pitavastatin
Brand: Livalo
$1.16Lowest NADAC
8Generic mfrs
$182.6MCY24 Part D spend
Compare →
05
Rosuvastatin
Brand: Crestor
$0.035Lowest NADAC
18Generic mfrs
$716.1MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.